|
Volumn 15, Issue 6, 2001, Pages 997-999
|
Do Transcriptionally silent BCR-ABL cells persist in CML patients in molecular remission after stem cell transplantation? [7]
a a a b a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
BCR ABL PROTEIN;
INTERFERON;
ADULT;
ALLOGENIC BONE MARROW TRANSPLANTATION;
ALLOGRAFT;
BLOOD;
BLOOD CELL;
BONE MARROW;
CANCER RECURRENCE;
CELL ACTIVATION;
CHIMERA;
CHRONIC MYELOID LEUKEMIA;
CLINICAL ARTICLE;
CONTROLLED STUDY;
CYTOGENETICS;
DONOR;
FEMALE;
FLUORESCENCE IN SITU HYBRIDIZATION;
FUSION GENE;
GENDER;
GENE EXPRESSION;
GENE LOCUS;
GENE PROBE;
GENE REARRANGEMENT;
GENETIC TRANSCRIPTION;
GRAFT VERSUS LEUKEMIA EFFECT;
HEMATOPOIESIS;
HEMATOPOIETIC CELL;
HUMAN;
LETTER;
LEUKEMIA REMISSION;
MALE;
MOLECULAR BIOLOGY;
MONITORING;
POLYMERASE CHAIN REACTION;
PRIORITY JOURNAL;
RECIPIENT;
REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;
SAMPLE;
SENSITIVITY AND SPECIFICITY;
SEQUENTIAL ANALYSIS;
SILENT GENE;
STEM CELL TRANSPLANTATION;
T LYMPHOCYTE;
TANDEM REPEAT;
X CHROMOSOME;
Y CHROMOSOME;
|
EID: 0034983734
PISSN: 08876924
EISSN: None
Source Type: Journal
DOI: 10.1038/sj.leu.2402136 Document Type: Letter |
Times cited : (3)
|
References (8)
|